Arcellx (ACLX) Return on Assets (2022 - 2025)

Arcellx's (ACLX) quarterly Return on Assets came in at 0.0% in Q4 2025, little changed year-on-year from 0.0% in Q4 2024, and down 6.3% quarter-over-quarter from 0.0% in Q3 2025.

Arcellx (ACLX) Return on Assets (2022 - 2025) Analysis & Trends

Arcellx's Return on Assets history runs 4 years deep, the most recent figure standing at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Assets changed 0.0% year-over-year to 0.0% in Q4 2025; TTM through Dec 2025 was 0.0%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
  • Return on Assets slipped to 0.0% in Q4 2025 per ACLX's latest filing, from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q3 2024 and bottomed at 0.01% in Q1 2022.
  • The 4-year median for Return on Assets is 0.0% (2023), against an average of 0.0%.
  • Biggest YoY gain for Return on Assets was 0 bps in 2023; the steepest drop was 0 bps in 2023.
  • Year by year, Return on Assets stood at 0.01% in 2022, then soared by 83 bps to 0.0% in 2023, then slumped by 48 bps to 0.0% in 2024, then slumped by 150 bps to 0.0% in 2025.
  • Per Business Quant, the three latest ACLX Return on Assets figures stand at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -0.69%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -0.01%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -0.80%
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 0.00%
10 Arcellx 6.48 Bn 6.48 Bn - 0.00%

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%
Dec 31, 2022 -0.01%
Sep 30, 2022 -0.01%
Jun 30, 2022 0.00%
Mar 31, 2022 -0.01%